Affordable Access

Publisher Website

The effects of hormone therapy, estrogen therapy and tibolone on apoptosis and cyclin D1expression in postmenopausal vaginal epithelium

Authors
Journal
European Journal of Obstetrics & Gynecology and Reproductive Biology
0301-2115
Publisher
Elsevier
Publication Date
Volume
121
Issue
1
Identifiers
DOI: 10.1016/j.ejogrb.2004.11.029
Keywords
  • Vagina
  • Hormone Therapy
  • Tibolone
  • Apoptosis
  • Cyclin D1
  • Bcl-2
  • Bax
Disciplines
  • Chemistry
  • Design
  • Medicine

Abstract

Abstract Objective: To investigate the effects of hormone therapy, estrogen therapy and tibolone on markers of apoptosis including bcl-2, and bax and cyclin D 1 expression in postmenopausal vaginal epithelium. Study design: Thirty postmenopausal women were randomized to the treatment protocols (0.625 mg conjugated equine estrogen (CEE) + 2.5 mg medroxyprogesterone acetate (MPA); 2 mg estradiol valerate; 2.5 mg tibolone). After baseline vaginal biopsy, control biopsies were performed after 70 days following the initiation of the therapy. Bcl-2, bax, Bcl-2/bax ratio, cyclin D 1 measurements were performed immunohistochemically. Data were analyzed by Kruskal–Wallis, Mann–Whitney U and Wilcoxon tests. Results: After the treatment period the above-mentioned parameters were not different among the groups except for cyclin D 1 levels. Cyclin D 1 expression was found to be strong in patients with treated estradiol valerate. Conclusions: The effects of estrogen on cyclin D 1 expression were not detected with tibolone or with the addition of progesterone to estrogen in the vaginal epithelium. Cyclin D 1 appeared to have stronger effects on the estrogen related proliferation compared to apoptotic markers in vaginal epithelial cells.

There are no comments yet on this publication. Be the first to share your thoughts.